Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Human topoisomerase II-DNA interaction study by using atomic force microscopy.

Alonso-Sarduy L, Roduit C, Dietler G, Kasas S.

FEBS Lett. 2011 Oct 3;585(19):3139-45. doi: 10.1016/j.febslet.2011.08.051. Epub 2011 Sep 6.

2.

Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.

Bechert T, Diekmann S, Arndt-Jovin DJ.

J Biomol Struct Dyn. 1994 Dec;12(3):605-23.

PMID:
7727061
3.

Revealing the mode of action of DNA topoisomerase I and its inhibitors by atomic force microscopy.

Argaman M, Bendetz-Nezer S, Matlis S, Segal S, Priel E.

Biochem Biophys Res Commun. 2003 Feb 14;301(3):789-97.

PMID:
12565850
4.

Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from Escherichia coli.

Ullsperger C, Cozzarelli NR.

J Biol Chem. 1996 Dec 6;271(49):31549-55.

5.

Mechanisms of chiral discrimination by topoisomerase IV.

Neuman KC, Charvin G, Bensimon D, Croquette V.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):6986-91. doi: 10.1073/pnas.0900574106. Epub 2009 Apr 9.

6.

Local sensing of global DNA topology: from crossover geometry to type II topoisomerase processivity.

Timsit Y.

Nucleic Acids Res. 2011 Nov 1;39(20):8665-76. doi: 10.1093/nar/gkr556. Epub 2011 Jul 15.

7.

Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases.

Charvin G, Bensimon D, Croquette V.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9820-5. Epub 2003 Aug 5.

8.

Molecular structure of human topoisomerase II alpha revealed by atomic force microscopy.

Nettikadan SR, Furbee CS, Muller MT, Takeyasu K.

J Electron Microsc (Tokyo). 1998;47(6):671-4.

PMID:
9972548
9.

DNA G-segment bending is not the sole determinant of topology simplification by type II DNA topoisomerases.

Thomson NH, Santos S, Mitchenall LA, Stuchinskaya T, Taylor JA, Maxwell A.

Sci Rep. 2014 Aug 21;4:6158. doi: 10.1038/srep06158.

10.

Mitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements.

Kawamura R, Pope LH, Christensen MO, Sun M, Terekhova K, Boege F, Mielke C, Andersen AH, Marko JF.

J Cell Biol. 2010 Mar 8;188(5):653-63. doi: 10.1083/jcb.200910085. Epub 2010 Mar 1.

11.

Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism.

Schoeffler AJ, Berger JM.

Biochem Soc Trans. 2005 Dec;33(Pt 6):1465-70. Review.

PMID:
16246147
12.

DNA supercoiling and relaxation by ATP-dependent DNA topoisomerases.

Fisher LM, Austin CA, Hopewell R, Margerrison EE, Oram M, Patel S, Plummer K, Sng JH, Sreedharan S.

Philos Trans R Soc Lond B Biol Sci. 1992 Apr 29;336(1276):83-91. Review.

PMID:
1351300
13.

DNA disentangling by type-2 topoisomerases.

Buck GR, Zechiedrich EL.

J Mol Biol. 2004 Jul 23;340(5):933-9.

PMID:
15236957
14.

Preferential relaxation of positively supercoiled DNA by E. coli topoisomerase IV in single-molecule and ensemble measurements.

Crisona NJ, Strick TR, Bensimon D, Croquette V, Cozzarelli NR.

Genes Dev. 2000 Nov 15;14(22):2881-92.

15.

Crystal structure of an intact type II DNA topoisomerase: insights into DNA transfer mechanisms.

Graille M, Cladière L, Durand D, Lecointe F, Gadelle D, Quevillon-Cheruel S, Vachette P, Forterre P, van Tilbeurgh H.

Structure. 2008 Mar;16(3):360-70. doi: 10.1016/j.str.2007.12.020.

16.
17.

Computational analysis of the chiral action of type II DNA topoisomerases.

Klenin K, Langowski J, Vologodskii A.

J Mol Biol. 2002 Jul 5;320(2):359-67.

PMID:
12079392
18.

Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification.

Hardin AH, Sarkar SK, Seol Y, Liou GF, Osheroff N, Neuman KC.

Nucleic Acids Res. 2011 Jul;39(13):5729-43. doi: 10.1093/nar/gkr109. Epub 2011 Mar 17.

19.

Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.

Seol Y, Gentry AC, Osheroff N, Neuman KC.

J Biol Chem. 2013 May 10;288(19):13695-703. doi: 10.1074/jbc.M112.444745. Epub 2013 Mar 18.

20.

A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIalpha.

Dhawan V, Swaffar DS.

Anticancer Drugs. 1999 Apr;10(4):397-404.

PMID:
10378675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk